Test Price
2,800 AED✅ Home Collection Available
GUSB Gene Mucopolysaccharidosis Type VII (MPS VII) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The GUSB Gene NGS test sequences the entire coding region of the GUSB gene to identify pathogenic variants causing Mucopolysaccharidosis Type VII (MPS VII, Sly syndrome) – a rare autosomal recessive lysosomal storage disease. This high-resolution analysis provides definitive molecular confirmation, enabling early diagnosis, carrier detection, and targeted genetic counseling.
| Feature | Our NGS Test (UAE) | Closest Alternative (Biochemical Enzyme Assay) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) with full gene coverage | Fluorometric enzyme activity (β‑glucuronidase) |
| Diagnostic Sensitivity | >99% for point mutations & copy number variants | ~90% – may miss pseudo‑deficiency or mild variants |
| Turnaround Time | 3–4 Weeks | 2–3 weeks (but requires viable cells) |
| Cost (AED) | 2800 | 1800–2200 (often not covered by insurance) |
Physician Insight & Safety Protocols
“As a clinical geneticist, I emphasize that a positive GUSB gene result must be correlated with clinical symptoms, enzymatic activity, and urinary glycosaminoglycans. Genetic findings alone do not dictate disease severity; family history and multi‑disciplinary assessment remain paramount. Never discontinue any prescribed enzyme replacement or supportive therapy without consulting your treating physician.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication Warning
⚠ Do not discontinue prescribed medication without consulting your doctor.
Genetic test results are not a substitute for ongoing clinical management. Any changes to therapy must be guided by the treating physician based on comprehensive assessment.
Exclusion Criteria & Red Flags
Exclusion Criteria (Do Not Proceed Without Physician Clearance)
- Acute intercurrent illness with fever or respiratory distress
- Severe coagulopathy or bleeding disorder uncontrolled
- Lack of informed consent prior to genetic counseling
- Minor without parental/legal guardian consent
Emergency Red Flags (Seek Immediate Care)
- Sudden neurological deterioration, seizures
- Severe skeletal pain or joint contractures worsening
- Airway obstruction or stridor
- Suspected spinal cord compression
Patient FAQ & Clinical Guidance
1. What is the GUSB gene NGS test and why is it ordered?
The GUSB gene NGS test detects disease‑causing mutations in the GUSB gene to confirm or exclude Mucopolysaccharidosis Type VII (Sly syndrome). It is indicated for patients with clinical features such as coarse facies, hepatosplenomegaly, skeletal dysplasia, and recurrent infections, or for carrier screening in families with a known mutation.
2. How should I prepare and what sample is required?
No special preparation is needed; a simple blood sample, extracted DNA, or a drop of blood on an FTA card is sufficient for this analysis. We strongly recommend a pre‑test genetic counseling session to draw a pedigree chart of affected family members, which optimizes result interpretation and familial risk assessment.
3. Can this test be performed on minors and how long do results take?
Yes, pediatric testing is permitted with informed parental consent and clinical justification; results are typically available within 3 to 4 weeks. All minors’ services strictly comply with DHA pediatric consent protocols. A telephonic post‑test clinical discussion is included to guide next steps.
UAE Regulatory & Data Privacy Adherence
This service is fully compliant with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is handled with strict confidentiality and in accordance with the highest data protection standards. The laboratory is operated by DNA Labs UAE under DHA Facility License Number 1143, ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Genetic counseling is integrated into the service to ensure informed decision‑making.
Clinical & Logistical Metadata
| Test Name | GUSB Gene Full Sequencing – Mucopolysaccharidosis Type VII (MPS VII) Genetic Test |
| Price (AED) | 2800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (or alternative specimens: Extracted DNA, FTA card) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full gene coverage |
| ICD-10-CM Code | E76.22 |
| LOINC Code | 94451-4 |
| DHA Facility License & Laboratory Address Invariants | Laboratory Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DHA License Number: 1143 | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians